SCHEMBL7388692

SCHEMBL7388692

CCOC(=O)C1CCCCCCC(CSC(C)=O)C(=O)N1

nearest known ligand 0.43

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ACE P12821 5/20 0.39
ALDH1A1 P00352 4/20 0.35
TSHR P16473 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7382068 0.87 ACE (0.40) ACE
SCHEMBL7386461 0.83 TSHR (0.50) ACETSHR
SCHEMBL7386472 0.83 ACE (0.46) ACE
SCHEMBL7385804 0.83 ACE (0.46) ACE
SCHEMBL7386691 0.82 ACE (0.42) ACE
SCHEMBL7386753 0.77 ALDH1A1 (0.40) ALDH1A1TSHR
SCHEMBL7390342 0.77 TLR4 (0.43) ALDH1A1TSHR
SCHEMBL7392788 0.77 ACE (0.35) ACE
SCHEMBL7392789 0.77 ACE (0.35) ACE
SCHEMBL7386602 0.76 ALDH1A1 (0.37) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5426103-A Endopeptidase inhibitors; condensing macrocylic compound with a thioic acid or salt therof; possible esterification, salt formation, deslating, deprotecting, deesterifying of function-al groups CIBA-GEIGY CORPORATION (US) 1995-06-20 US disclosed
US-5244889-A Treatment of cardiovascular disorders CIBA-GEIGY CORPORATION (US) 1993-09-14 US disclosed
EP-0544620-A1 Macrocyclic lactams as inhibitors of atrial natriuretic factors (ANF)-degrading neutral endopeptidase (NEP) CIBA-GEIGY AG (CH) 1993-06-02 EP disclosed